Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.02.015Source: DataRank Database

Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas is a research paper published in Journal of Cystic Fibrosis (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 1.63)OA: greenTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

M. Skalland ORCID,Scott D. Sagel ORCID,Bonnie W. Ramsey ORCID,Nicole Mayer-Hamblett ORCID,George Retsch‐Bogart ORCID

Live enrichment

PubMed:35260354 PMC:PMC9441469 OpenAlex:https://openalex.org/W4221003911

Cystic Fibrosis Foundation

Grant: ACCURS03Y2

NIDDK NIH HHS

Grant: P30 DK089507

NHLBI NIH HHS

Grant: U01 HL114589

NCATS NIH HHS

Grant: UL1 TR002319

National Institutes of Health

Grant: UL1TR002489

National Institutes of Health

Grant: UL1TR1425

National Institutes of Health

Grant: UL1TR001108

NCATS NIH HHS

Grant: UL1 TR001425

NCATS NIH HHS

Grant: UL1 TR002535

National Institutes of Health

Grant: UL1TR001082

NHLBI NIH HHS

Grant: U01 HL114623

National Institutes of Health

Grant: 5UL1TR001425-03

Cincinnati Center for Clinical and Translational Sciences and Training

National Institutes of Health

Grant: 5U01HL114623-03

OPTIMIZE - CCC - Lead Application

National Institutes of Health

Grant: 3UL1TR002489-02S1

North Carolina Translational and Clinical Science Institute (NC TraCS)

National Institutes of Health

Grant: 5UL1TR001082-05

Colorado Clinical and Translational Sciences Institute

National Institutes of Health

Grant: 3UL1TR002319-02S1

Transform Dissemination and Implementation Science in CTSA Programs

National Institutes of Health

Grant: 4U01HL114589-04

OPTIMIZE - DCC

National Institutes of Health

Grant: 3UL1TR002535-03S1

NIH Prior Approval Process Professional

National Institutes of Health

Grant: 5P30DK089507-02

Translational Research Center for Expedite Novel Therapies in Cystic Fibrosis

National Institutes of Health

Grant: 3UL1TR001108-02S1

Indiana Clinical and Translational Sciences Institute

FWCI

1.63

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9441469

journalhttps://doi.org/10.1016/j.jcf.2022.02.015

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35260354

Fields of Study

Cystic Fibrosis Research AdvancesPneumonia and Respiratory InfectionsNosocomial Infections in ICU0301 basic medicine03 medical and health sciences0302 clinical medicineChildHumansAnti-Bacterial AgentsAzithromycinBiomarkersC-Reactive ProteinCystic FibrosisLeukocyte L1 Antigen ComplexPeroxidasePseudomonas

MeSH Terms

Anti-Bacterial AgentsC-Reactive ProteinChildCystic FibrosisHumansPeroxidasePseudomonasBiomarkersAzithromycinLeukocyte L1 Antigen Complex

Keywords

AzithromycinMedicineCystic fibrosisExacerbationCalprotectinInternal medicineMyeloperoxidaseGastroenterologyPlaceboC-reactive proteinAbsolute neutrophil countImmunologyInflammationAntibioticsPathologyChemotherapyMicrobiologyDiseasePseudomonasInflammatory MarkersAnti-Bacterial AgentsHumansChildLeukocyte L1 Antigen ComplexBiomarkersPeroxidase

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being